Hospital Clínic de Barcelona

A phase II randomized study of neoadjuvant letrozole plus alpelisib for hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (NeO-ORB) (2019) Mayer IA, Prat A, Egle D, Blau S, Alejandro Perez Fidalgo J, Gnant M, Fasching P, et al. Journal article Critique of the 2017 epileptic seizure and epilepsy classifications (2019) Lüders H, Akamatsu N, Amina S, Baumgartner C, Benbadis S, Bermeo-Ovalle A, Bleasel A, et al. Journal article Glucocorticoid Doses and Acute-Phase Reactants at Giant Cell Arteritis Flare in a Randomized Trial of Tocilizumab (2019) Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, Brouwer E, et al. Journal article Prevention and management of adverse events of novel agents in multiple myeloma: A consensus of the European Myeloma Network (2018) Ludwig H, Delforge M, Facon T, Einsele H, Gay F, Moreau P, Avet-Loiseau H, et al. Journal article, Review article From interventionist imaging to intraoperative guidance: New perspectives by combining advanced tools and navigation with radio-guided surgery De la imagen intervencionista a la guía intraoperatoria: nuevas perspectivas combinando herramientas avanzadas y navegación con la cirugía radioguiada (2018) Vidal-Sicart S, Olmos RV, Nieweg OE, Faccini R, Grootendorst MR, Wester HJ, Navab N, et al. Journal article A multicentric, open-label, randomized, comparative clinical trial of two different doses of expanded hbm-mscs plus biomaterial versus iliac crest autograft, for bone healing in nonunions after long bone fractures: Study protocol (2018) Gomez-Barrena E, Padilla-Eguiluz NG, Avendano-Sola C, Payares-Herrera C, Velasco-Iglesias A, Torres F, Rosset P, et al. Journal article Computer-assisted prediction of clinical progression in the earliest stages of AD (2018) Rhodius-Meester HF, Liedes H, Koikkalainen J, Wolfsgruber S, Coll-Padros N, Kornhuber J, Peters O, et al. Journal article Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension study (2018) Feagan BG, Panes J, Ferrante M, Kaser A, D'Haens GR, Sandborn WJ, Louis E, et al. Journal article Efficacy and safety of nilotinib in patients with kit-mutated metastatic or inoperable melanoma: Final results from the global, single-arm, phase ii team trial (2017) Guo J, Carvajal RD, Dummer R, Hauschild A, Daud A, Bastian BC, Markovic SN, et al. Journal article Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation (2017) Van Gelder M, De Wreede LC, Bornhaeuser M, Niederwieser D, Karas M, Anderson NS, Gramatzki M, et al. Journal article